|
|
Speakers Details of invited speakers will be posted to the web site as information becomes available. Invited Speakers
Peter Mathieson went to school in Cornwall, then qualified in Medicine with honours from London Hospital Medical College in 1983. After junior posts in and around the West End of London, he went to Cambridge as an MRC training fellow, studying for a PhD which was awarded by Cambridge University in 1992. After a further MRC-funded fellowship during which he worked with Professors Peter Lachmann and Doug Fearon on complement/immunology, he moved to Bristol in 1995 as the foundation Professor of Renal Medicine at Bristol University and Honorary Consultant Nephrologist, North Bristol NHS Trust. Peter was elected Fellow of the Academy of Medical Sciences in 1999. In 2007 he was elected as President of the Renal Association (the youngest ever!) and also became Head of the University Department of Clinical Science at North Bristol. He was also appointed as Director of Research & Development for the North Bristol NHS Trust. Between 2003 and 2007 he chaired the Research Grants Committee of Kidney Research UK [formerly National Kidney Research Fund]. He was a member of the Renal Association Clinical Trials committee from 1996 to 2007 and its chairman between 2000 and 2003. In 2008 Peter was appointed Dean of the Faculty of Medicine and Dentistry. Peter's major clinical interest is in autoimmune renal diseases (glomerulonephritis, systemic vasculitis, systemic lupus erythematosus etc.). His research interests are in human glomerular cell biology and regulation of glomerular permeability, and he leads the group in the Academic Renal Unit that in recent years has made significant contributions to the study of podocytes and glomerular endothelial cells, interactions between them and factors in the causation and treatment of proteinuria. The work of the group has attracted major research grant funding of around £5million from sources including Medical Research Council, Wellcome Trust and Kidney Research UK. In any spare time, Peter enjoys hill-walking, travelling and spending time with his family.
Professor Cathy Shanahan obtained her BSc(Hons) and PhD in Genetics from the University of Adelaide, Australia. She worked for CSIRO in Sydney, Australia before moving to the University of Cambridge as a post-doc in the Departments of Biochemistry and then Medicine. In 1995 she was appointed as a British Heart Foundation Basic Sciences Lecturer and in 2005 became a British Heart Foundation Senior Fellow in the Department of Medicine, University of Cambridge. In 2007 she took up the position of Professor of Cellular Signalling at King’s College London. Professor Shanahan is currently a member of the British Atherosclerosis Society (BAS) and served on its committee from 2001-2004, is a nucleus member of the Atherosclerosis Working Group of the European Cardiac Society and is a member of the British Society of Cardiovascular Research (BSCR) and the North American Vascular Biology Organisation (NAVBO). She is currently on the Editorial Boards of Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) (2002-), Current Cardiology Reviews (CCR) (2006-) and Kidney International (KI) (2007-).
Dr. Tonelli is an Alberta Heritage Foundation for Medical Research Population Health Scholar who spends 75% of his time conducting clinical and epidemiological research. His research is aimed at improving the care of people with chronic kidney disease and its major causes (hypertension, diabetes mellitus, and atherosclerosis). Specific areas of focus within these clinical populations include: identification and management of novel risk factors; designing new strategies to improve the efficiency of healthcare delivery; and determinants of access to high quality care. A unique aspect of Dr. Tonelli’s research program includes partnering with regional, provincial, and national decision-makers to ensure that the findings will be used to produce rational health policy. Dr. Tonelli supervises post-graduate medical trainees, MSc students, PhD students and post-doctoral fellows in clinical research. Dr. Tonelli is currently an Associate Professor in the Department of Medicine, Division of Nephrology and Immunology, at the University of Alberta (Edmonton, Canada). He is a member of the Canadian Society of Nephrology Scientific Committee for the Kidney Foundation of Canada, and the President of the Canadian Society of Nephrology. He is also the Chair of the Canadian Task Force for Preventive Health Care, a panel of experts that makes recommendations on clinical preventive services for Canada’s 36,000 family physicians. Internationally, Dr. Tonelli is a member of the council of the International Society of Nephrology and a member of the Board of Directors for Kidney Disease: Improving Global Outcomes (KDIGO). Dr. Tonelli is an Associate Editor for American Journal of Kidney Disease, the Cochrane Renal Group, and the Journal of Nephrology, and is a member of the Editorial Board for the Journal of the American Society of Nephrology (JASN). |
| Contact Us • Privacy |
Professor
Peter W Mathieson, Dean of Medicine and Dentistry Medicine and
Dentistry Faculty Office, University of Bristol, United Kingdom
Professor
Catherine Shanahan, Professor of Cellular Signalling,British Heart
Foundation, Senior Fellow King’s College London, United Kingdom 
Associate
Professor Marcello Tonelli, MD, SM, FRCPC Division of Nephrology Department of
Medicine, University of Alberta Edmonton, Alberta, Canada